- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Atai Life Sciences (ATAI)
Company Profile
| Quarter (USD) | Jun 25 | Mar 25 | Dec 24 | Sep 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 61.94 mm | 61.94 mm | 61.94 mm | 61.94 mm | 61.94 mm | 61.94 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 8.42 mm | 8.21 mm | 4.70 mm | 6.30 mm |
| Cash used (since last report) | n/a | n/a | 36.36 mm | 35.43 mm | 20.27 mm | 27.18 mm |
| Cash remaining | n/a | n/a | 25.58 mm | 26.51 mm | 41.67 mm | 34.76 mm |
| Runway (months of cash) | n/a | n/a | 3.0 | 3.2 | 8.9 | 5.5 |
| 13F holders | Current |
|---|---|
| Total holders | 76 |
| Opened positions | 7 |
| Closed positions | 20 |
| Increased positions | 13 |
| Reduced positions | 21 |
| 13F shares | Current |
|---|---|
| Total value | 13.11 bn |
| Total shares | 56.26 mm |
| Total puts | 50.30 k |
| Total calls | 77.80 k |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| Apeiron Investment | 33.89 mm | $62.69 mm |
| Galaxy Group Funding ECI U | 10.80 mm | $82.38 mm |
| MS Morgan Stanley | 3.04 mm | $3.52 bn |
| Walleye Capital | 2.26 mm | $2.63 bn |
| BlackRock | 1.27 mm | $1.47 bn |
| Brown University | 718.50 k | $833.46 mm |
| Woodline Partners | 535.05 k | $620.66 mm |
| Millennium Management | 441.73 k | $512.40 mm |
| Vanguard | 407.68 k | $472.91 mm |
| Two Sigma Investments | 407.18 k | $472.33 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Nov 25 | Cosmo Feilding-Mellen | Common Shares | Grant | Acquire A | No | No | 0 | 7,702,990 | 0.00 | 7,702,990 |
| 5 Nov 25 | Cosmo Feilding-Mellen | Stock Option Common Shares | Grant | Acquire A | No | No | 4.48 | 40,400 | 180.99 k | 40,400 |
| 5 Nov 25 | Cosmo Feilding-Mellen | Stock Option Common Shares | Grant | Acquire A | No | No | 4.48 | 103,000 | 461.44 k | 103,000 |
| 5 Nov 25 | Hershberg Robert | Stock Option Common Shares | Grant | Acquire A | No | No | 4.48 | 103,000 | 461.44 k | 103,000 |
| 5 Nov 25 | Hershberg Robert | Stock Option Common Shares | Grant | Acquire A | No | No | 1.35 | 62,394 | 84.23 k | 62,394 |
| 5 Nov 25 | Hershberg Robert | Stock Option Common Shares | Grant | Acquire A | No | No | 1.35 | 97,716 | 131.92 k | 97,716 |
| 5 Nov 25 | Hershberg Robert | Stock Option Common Shares | Grant | Acquire A | No | No | 1.35 | 456,011 | 615.61 k | 456,011 |
| 4 Nov 25 | Braunstein Scott | Stock Option Common Shares | Grant | Acquire A | No | No | 5.28 | 56,818 | 300.00 k | 56,818 |